Current Report Filing (8-k)
May 21 2019 - 5:27PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
May 17, 2019
|
STEMGEN, INC.
|
(Exact name of registrant as specified in charter)
|
|
|
|
Delaware
|
0-21555
|
54-1812385
|
(State of other jurisdiction
of incorporation)
|
(Commission
File Number)
|
(IRS Employer
Identification No.)
|
|
|
1 Performance Drive, Suite F
|
|
Angleton, Texas
|
77515
|
(Address of principal executive offices)
|
(Zip Code)
|
|
(832) 954-7569
|
Registrant’s telephone number, including area code
|
|
Not Applicable
|
(Former name or former address, if changed since last report)
|
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
|
|
[ ]
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
|
[ ]
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
|
[ ]
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
|
[ ]
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Securities registered pursuant to Section 12(g) of the Act:
|
|
|
Title of each class
|
Trading symbol(s)
|
Name of each exchange on which registered
|
Common stock, $0.001 par value
|
SGNI
|
OTC Pink
|
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company [ ]
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [ ]
ITEM 1.01 – Entry into Material Definitive Agreements
Joint Venture Agreement
On the 17
th
day of May 2019, StemGen, Inc. (“StemGen” “us”, “we”
or the “Company”) created a wholly owned subsidiary in Texas that entered into Joint Venture Agreement among, The Learning
Partnership.com (“TLP”), with its head office located in the United Kingdom, D3esports Corp., a Wyoming corporation,
and Dawson Racing, Inc., a Wyoming corporation. The mission of the Joint Venture is the integration of the technologies from the
three companies, into a single virtual-to-real motorsports-based Science, Technology, Engineering and Mathematics (STEM) enrichment
and collaboration learning environment, will drive the launch this year of an esports competition for school networks and their
students.
TLP has pioneered major advances in educational leadership, teaching and learner engagement over the past
decade, creating a social learning platform division for education, www.DendriteConnect.com. Dendrite Connect empowers students,
teachers and parents around the globe to engage in STEM programs, challenges, projects and careers. Dendrite Connect enables collaboration
between its members through content sharing, chat forums and networks of users and career opportunities tailored to each member
as they journey through education.
ITEM 3.02 – Unregistered Sale of Equity Securities
On the
1
st
day of February
2019, in 5 unrelated transactions, the Company issued 21,600 shares pursuant to 5 individual Stock Purchase Agreements.
The shares were issued without registration
in reliance on the exemption in Section 4(2) of the Securities Act of 1933 and Rule 506 of Regulation D thereunder. The Company
believes the exemption is available because the offering is made solely and only to the parties to the Stock Purchase Agreements
described in this report following comprehensive due diligence investigation without any public offering or solicitation.
ITEM 9.01 – Financial Statements and Exhibits
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
|
STEMGEN, INC.
|
|
|
|
|
Dated: May 21, 2019
|
/s/ Simon Dawson
|
|
Simon Dawson
|
|
President, Secretary, Treasurer, Principal Executive Officer,
Principal Financial and Accounting Officer and Sole Director
|
- 2 -
StemGen (CE) (USOTC:SGNI)
Historical Stock Chart
From May 2024 to Jun 2024
StemGen (CE) (USOTC:SGNI)
Historical Stock Chart
From Jun 2023 to Jun 2024